(Q46571097)

23 December 2017

MDMA

0 references

title

Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse (English)

1 reference

23 December 2017

0 references

1 reference

William E Fantegrossi

1

1 reference

23 December 2017

Christina L Kiessel

2

1 reference

23 December 2017

Richard De la Garza

3

1 reference

23 December 2017

James H Woods

4

1 reference

23 December 2017

publication date

1 September 2005

1 reference

23 December 2017

published in

Psychopharmacology

1 reference

23 December 2017

volume

181

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

529-536

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-0005-8

exact match

0 references

cites work

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-005-0005-8

Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists

21 January 2018

1 reference

12 December 2020

Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor

1 reference

12 December 2020

Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA.

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

12 December 2020

3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro

1 reference

12 December 2020

Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.

1 reference

12 December 2020

MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.

1 reference

12 December 2020

A psychomotor stimulant theory of addiction.

1 reference

12 December 2020

Head-twitch response induced by ergometrine in mice: behavioural evidence for direct stimulation of central 5-hydroxytryptamine receptors by ergometrine

1 reference

12 December 2020

Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors

1 reference

12 December 2020

Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems

1 reference

12 December 2020

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement

1 reference

12 December 2020

Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

1 reference

12 December 2020

Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration

1 reference

12 December 2020

Behavioral sensitivity to LSD: Dependency upon the pattern of central 5HT depletion

1 reference

12 December 2020

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

1 reference

12 December 2020

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

1 reference

12 December 2020

Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice

1 reference

12 December 2020

Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice

1 reference

12 December 2020

Intravenous administration of ecstasy (3,4-methylendioxymethamphetamine) enhances cortical and striatal acetylcholine release in vivo

1 reference

12 December 2020

10.1007/S00213-005-0005-8

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017